Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies – PubMed
Crisanti, C., Enrico, P., Fiorentini, A., Delvecchio, G., & Brambilla, P. | Journal of Affective Disorders | 1 November 2020
P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap
Smigielski, L., Kometer, M., Scheidegger, M., Stress, C., Preller, K. H., Koenig, T., & Vollenweider, F. X. | Human brain mapping | 21 Aug 2020
[Psychedelics in the treatment of substance use disorders and psychosis]
van den Brink, W., Breeksema, J. J., Vermetten, E., & Schoevers, R. A. | Tijdschrift Voor Psychiatrie | 1 August 2020
[Psychedelics for existential distress in terminally ill patients]
Schimmel, N., Breeksema, J. J., Veraart, J. K. E., van den Brink, W., & Schoevers, R. A. | Tijdschrift Voor Psychiatrie | 1 August 2020
Microdosing with psychedelics: what do we know?
Kuypers, K. P. C. | Tijdschrift Voor Psychiatrie | 1 Augustus 2020
[Psychedelics in the treatment of PTSD]
Vermetten, E., Krediet, E., Bostoen, T., Breeksema, J. J., Schoevers, R. A., & van den Brink, W. | Tijdschrift Voor Psychiatrie |1 August 2020
The Current Status of Psychedelics in Psychiatry
Nutt, D., & Carhart-Harris, R. | JAMA psychiatry | 29 July 2020
LSD-induced increases in social adaptation to opinions similar to one’s own are associated with stimulation of serotonin receptors
Duerler, P., Schilbach, L., Stämpfli, P., Vollenweider, F. X., & Preller, K. H. | Scientific reports | 22 July 2020
Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
Galvão-Coelho, N. L., de Menezes Galvão, A. C., de Almeida, R. N., Palhano-Fontes, F., Campos Braga, I., Lobão Soares, B., de Araujo, D. B. | Journal of Psychopharmacology | 10 Jul 2020
Historic psychedelic drug trials and the treatment of anxiety disorders
Weston, N. M., Gibbs, D., Bird, C. I., Daniel, A., Jelen, L. A., Knight, G., & Rucker, J. J. | Depression and Anxiety | 05 July 2020
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil
Jardim, A. V., Jardim, D. V., Chaves, B. R., Steglich, M., Ot’alora G, M., Mithoefer, M. C., Doblin, R. | Brazilian Journal of Psychiatry | 3 July 2020
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
Shiroma, P. R., Thuras, P., Wels, J., Albott, C. S., Erbes, C., Tye, S., & Lim, K. O. | Translational psychiatry | 26 June 2020
Spotlight commentary: REBUS and the anarchic brain
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 12 June 2020
A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy
Luoma, J. B., Chwyl, C., Bathje, G. J., Davis, A. K., & Lancelotta, R. | Journal Of Psychoactive Drugs | 12 June 2020
Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland
Kangaslampi, S., Hausen, A., & Rauteenmaa, T. | Journal of Psychoactive Drugs | 8 June 2020
Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism
van Mulukom, V., Patterson, R., & van Elk, M. | Psychopharmacology (Berl) | 29 May 2020
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., ... & Ramaekers, J. G. | Neuropsychopharmacology | 23 May 2020
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I)
Fu, D. J., Ionescu, D. F., Li, X., Lane, R., Lim, P., Sanacora, G., ... & Canuso, C. M. | 12 May 2020 | The Journal of clinical psychiatry
MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
Morgan, L. | Annals of General Psychiatry | 12 May 2020
Psilocybin: from ancient magic to modern medicine
Nichols, D. E. | The Journal of Antibiotics | 12 May 2020
Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Six Phase 2 Trials
Jerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., ... & Doblin, R. | Psychopharmacology | 11 May 2020
Psychedelic treatment of functional neurological disorder: a systematic review
Butler, M., Seynaeve, M., Nicholson, T. R., Pick, S., Kanaan, R. A., Lees, A., ... & Rucker, J. | Therapeutic Advances in Psychopharmacology | 11 May 2020
Can Psychedelics Alleviate Symptoms of Cluster Headache and Accompanying Mental Health Problems? A Case Report Involving Hawaiian Baby Woodrose
Johnson, S., & Black, Q. C. | Journal of Psychoactive Drugs | 7 May 2020
Psilocybin and LSD Have No Long-Lasting Effects in an Animal Model of Alcohol Relapse
Meinhardt, M. W., Güngör, C., Skorodumov, I., Mertens, L. J., & Spanagel, R. | Neuropsychopharmacology | 5 May 2020
Chronic pain and psychedelics: a review and proposed mechanism of action
Castellanos, J. P., Woolley, C., Bruno, K. A., Zeidan, F., Halberstadt, A., & Furnish, T. | Regional Anesthesia & Pain Medicine | 4 May 2020